What does CUSIP 00972D105 represent in this 13F holders report?

CUSIP 00972D105 is the security identifier for AKBA - Akebia Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AKBA - Akebia Therapeutics, Inc. - Common Stock in Q2 2015?

70 institutional investors reported AKBA - Akebia Therapeutics, Inc. - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

Akebia Therapeutics, Inc. - Common Stock (AKBA)

CUSIP: 00972D105

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock
Shares outstanding: 263,222,327
Total 13F shares: 12,209,438
Share change: +5,189,071
Total reported value: $125,630,881
Put/Call ratio: 83%
Price per share: $10.29
Number of holders: 70
Value change: +$52,360,330
Number of buys: 57
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 00972D105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Novo Holdings A/S	13F	Company	0.58%	1,516,387	$16,847,000	—	31 Mar 2015	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.47%	1,238,436	$13,759,000	—	31 Mar 2015	13F
STIFEL FINANCIAL CORP	13F	Company	0.17%	444,704	$11,110,000	—	31 Mar 2015	13F
FMR LLC	13F	Company	0.28%	724,200	$8,046,000	—	31 Mar 2015	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.23%	597,363	$6,637,000	—	31 Mar 2015	13F
HealthCor Management, L.P.	13F	Company	0.23%	594,534	$6,605,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	0.18%	474,023	$5,266,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	0.11%	287,842	$3,198,000	—	31 Mar 2015	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.1%	257,090	$2,121,000	—	31 Mar 2015	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.05%	138,676	$1,541,000	—	31 Mar 2015	13F
STATE STREET CORP	13F	Company	0.04%	103,294	$1,145,000	—	31 Mar 2015	13F
Cormorant Asset Management, LP	13F	Company	0.04%	100,300	$1,114,000	—	31 Mar 2015	13F
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/	13F	Company	0.04%	94,000	$1,044,000	—	31 Mar 2015	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.03%	86,492	$961,000	—	31 Mar 2015	13F
NORTHERN TRUST CORP	13F	Company	0.03%	80,884	$899,000	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.03%	73,754	$819,000	—	31 Mar 2015	13F
MORGAN STANLEY	13F	Company	0.02%	55,825	$620,000	—	31 Mar 2015	13F
Employees Retirement System of Texas	13F	Company	0.02%	50,000	$556,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	42,938	$477,000	—	31 Mar 2015	13F
Bank of New York Mellon Corp	13F	Company	0.01%	34,914	$388,000	—	31 Mar 2015	13F
EMERALD ADVISERS, LLC	13F	Company	0.02%	42,910	$354,000	—	31 Mar 2015	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	31,650	$352,000	—	31 Mar 2015	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.01%	28,937	$321,000	—	31 Mar 2015	13F
CREDIT SUISSE AG/	13F	Company	0.01%	27,742	$309,000	—	31 Mar 2015	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.01%	23,900	$266,000	—	31 Mar 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.01%	22,506	$250,000	—	31 Mar 2015	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	21,012	$234,000	—	31 Mar 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.01%	20,895	$233,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.01%	20,328	$226,000	—	31 Mar 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	19,000	$211,000	—	31 Mar 2015	13F
DEARBORN PARTNERS LLC	13F	Company	0.01%	18,020	$200,000	—	31 Mar 2015	13F
ProShare Advisors LLC	13F	Company	0.01%	17,902	$199,000	—	31 Mar 2015	13F
Swiss National Bank	13F	Company	0.01%	17,200	$191,000	—	31 Mar 2015	13F
A.R.T. Advisors, LLC	13F	Company	0.01%	17,002	$188,000	—	31 Mar 2015	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	14,544	$162,000	—	31 Mar 2015	13F
GROUP ONE TRADING LLC	13F	Company	0%	12,775	$142,000	—	31 Mar 2015	13F
Rotella Capital Management, Inc.	13F	Company	0%	12,500	$139,000	—	31 Mar 2015	13F
UBS Group AG	13F	Company	0%	11,876	$132,000	—	31 Mar 2015	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0%	11,659	$130,000	—	31 Mar 2015	13F
TEACHERS ADVISORS, LLC	13F	Company	0%	11,062	$123,000	—	31 Mar 2015	13F
ALPS ADVISORS INC	13F	Company	0%	10,041	$112,000	—	31 Mar 2015	13F
Deutsche Girozentrale DekaBank	13F	Individual	0%	9,500	$106,000	—	31 Mar 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	8,113	$91,000	—	31 Mar 2015	13F
Nationwide Fund Advisors	13F	Company	0%	5,580	$62,000	—	31 Mar 2015	13F
FIFTH THIRD BANCORP	13F	Company	0%	5,100	$57,000	—	31 Mar 2015	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	4,926	$54,728	—	31 Mar 2015	13F
DEUTSCHE BANK AG\	13F	Company	0%	4,415	$49,000	—	31 Mar 2015	13F
BLACKROCK ADVISORS LLC	13F	Company	0%	3,686	$41,000	—	31 Mar 2015	13F
CITIGROUP INC	13F	Company	0%	3,091	$34,000	—	31 Mar 2015	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0%	2,873	$32,000	—	31 Mar 2015	13F

Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2015

As of 30 Jun 2015, Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,209,438 shares. The largest 10 holders included EAGLE ASSET MANAGEMENT INC, FMR LLC, Novo A/S, BlackRock Fund Advisors, BALYASNY ASSET MANAGEMENT LLC, VANGUARD GROUP INC, Marshall Wace LLP, RENAISSANCE TECHNOLOGIES LLC, EMERALD MUTUAL FUND ADVISERS TRUST, and STATE STREET CORP. This page lists 70 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

Q2 2015 holders

Holder diff

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.